Related by context. Frequent words. (Click for all words.) 69 addressing idiopathic pulmonary 69 optical biosensors 69 Locked Nucleic Acid LNA 69 includes iFinix RealTime 69 Lipid Polymer Micelle LPM 68 oncolytic virus therapies 68 Bone Augmentation Material 68 system vaporizes unformulated 68 fibrosis IPF 67 include bioavailability enhancement 67 Cephalon Oncology 67 proprietary biomaterials 67 TIMERx 66 reformulates existing FDA 66 NASDAQ CRXL 66 Sangamo ZFP technology 66 topically delivered 66 Inc. Nasdaq NEXM 66 comprise Alnylam RNAi 66 LabCorp combines 66 Patented SDC 66 Amgen discovers develops 66 using BioSante patented 66 Crucell NV NYSE Euronext 65 topical non steroidal 65 programs visit http:/www.bionovo.com 65 Amphion Innovations plc 65 Currently RegeneRx 65 Nasdaq MNKD focuses 65 developing Zerenex TM 65 treat male hypogonadism 65 Search amNY.com Web 65 Search dailypress.com Web 65 electrolytically generated source 65 Amgen discovers develops manufactures 65 ABSTRACT FULL TEXT 65 low toxicity bioscience 65 mediate RNAi 64 Dicer Substrate Technology 64 Fleximer 64 Antigen Express comprise immunotherapeutics 64 Auxilium transmucosal film 64 R MMFM R 64 Search OrlandoSentinel.com Web 64 By MIKE McKIBBIN 64 nitric oxide donating 64 superwide digital inkjet printers 64 Biomagnetics Diagnostics Corporation 64 NexACT R 64 based pretargeting methods 64 PNP inhibitor 64 orthobiologic 64 targeted immunotherapies 64 Baxa customer 64 CyDex Pharmaceuticals Inc. 64 * Azixa 64 Regulatory Disclosure 63 By DANIE HARRELSON 63 Currently Exelixis 63 Nasdaq CRXL 63 Search Newsday.com Web 63 produces Chrysler Jeep 63 By MIKE SACCONE 63 Fortical R 63 includes investigational compounds 63 proprietary Mimetic Ligand 63 overactive bladder AA# 63 topical anti infective 63 malignant infectious 63 iFinix Trader 63 leading lipid nanoparticle 63 novel anti infective 63 differentiated therapeutics 63 multi kinase inhibitor 63 VEGFR2 inhibitor 63 By Lisa Eckelbecker 63 stable nucleic acid 63 COX FP Reuters NCOX.PA 63 approvals revisions mgmt 63 provides adenoviral reagents 63 generation nucleoside analog 63 Captisol 63 Nanomanufacturing Technology TM 63 candidate ridaforolimus 63 Inc. Nasdaq INFI 63 aesthetic medicine BioLook 63 vivo electroporation 63 Jetrion ® industrial 63 www.aveopharma.com 63 triple VEGF receptor 63 Alnylam maintains 63 Nanobody 63 By THERESA CAMPBELL 63 Initiates Phase II 63 oral transdermal 63 By Laurie Kulikowski 63 By Supun Dias 62 regarding Aethlon Medical 62 liposomal formulation 62 CD#.# DOES NOT ENDORSE 62 By Naoise O